i-STAT CG4+ cartridge (blue), List No. 03P85-50. UDI (01) 00054749002269 - Product Usage: The i-STAT CG4+ cartridge is intended for the quantitative measurement of lactate, pH, pCO2, and pO2 in venous, arterial or capillary whole blood.
Publicado el 26 de febrero de 2020 · Inicio del retiro: 15 de enero de 2020
Resumen
FDA registra el retiro Z-1263-2020 de dispositivos médicos de Clase II, publicado el 26 de febrero de 2020 e iniciado el 15 de enero de 2020. Empresa responsable: Abbott Point Of Care Inc.; Estado: Finalizado; Cantidad reportada: 99,850; Lote: All lots are affected. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
The I-STAT BLUE CHEM8+ and CG4+ cartridges are not FDA cleared and do not have CLIA waived status. CLIA recognizes two types of laboratory tests: waived and non-waived. Different CLIA standards apply to waived and non-waived tests as well as the facilities that perform these types of tests. The i-STAT CHEM8+ cartridge contains nine measured assays (sodium, potassium, chloride, blood urea nitrogen (BUN), ionized calcium, TCO2, glucose, creatinine and hematocrit) and is categorized as a CLIA waived test for venous whole blood samples, meaning this cartridge could be used in a facility with a CLIA Certificate of Waiver as a waived test.
Qué hacer
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Abbott Point Of Care Inc.
- Distribuidor
- US Nationwide distribution.
- Lote
- All lots are affected
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDAi-STAT EG6+ cartridge; List Number: 03P77-25;6 de mayo de 2026
- FDAi-STAT EG7+ cartridge; List Number: 03P76-25;6 de mayo de 2026
- FDAi-STAT G3+ cartridge; List Number: 03P78-26;6 de mayo de 2026
- FDAi-STAT EG6+ cartridge. List Number: 03P77-25.24 de septiembre de 2025
- FDAAtellica CH High Sensitivity C-Reactive Protein (HsCRP) Calibrator - Product Usage: For in vitro diagnostic26 de febrero de 2020
- FDAPilling Aortic Punch, 4.0 mm Standard Tip, REF 35344026 de febrero de 2020
Preguntas sobre este retiro
¿i-STAT CG4+ cartridge (blue), List No. 03P85-50. UDI (01) 00054749002269 - Product Usage: The i-STAT CG4+ cartridge is intended for the quantitative measurement of lactate, pH, pCO2, and pO2 in venous, arterial or capillary whole blood. fue retirado del mercado?
Sí. FDA publicó el retiro Z-1263-2020 el 26 de febrero de 2020. Peligro reportado: The I-STAT BLUE CHEM8+ and CG4+ cartridges are not FDA cleared and do not have CLIA waived status. CLIA recognizes two types of laboratory tests: waived and non-waived. Different CLIA standards apply to waived and non-waived tests as well as the facilities that perform these types of tests. The i-STAT CHEM8+ cartridge contains nine measured assays (sodium, potassium, chloride, blood urea nitrogen (BUN), ionized calcium, TCO2, glucose, creatinine and hematocrit) and is categorized as a CLIA waived test for venous whole blood samples, meaning this cartridge could be used in a facility with a CLIA Certificate of Waiver as a waived test.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit